Renaissance Technologies’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Renaissance Technologies’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-59,666	Closed	-$2.37M	–	3665
2016 Q3	$2.37M	Buy	59,666 +22,401	+60%	+$250K	﹤0.01%	2083
2016 Q2	$468K	Buy	37,265 +7,300	+24%	+$68K	﹤0.01%	2816
2016 Q1	$245K	Sell	29,965 -4,400	-13%	-$33.2K	﹤0.01%	3036
2015 Q4	$345K	Sell	34,365 -2,700	-7%	-$28K	﹤0.01%	2851
2015 Q3	$358K	Buy	37,065 +11,700	+46%	+$164K	﹤0.01%	2720
2015 Q2	$438K	Buy	25,365 +18,520	+271%	+$271K	﹤0.01%	2764
2015 Q1	$75K	Buy	6,845 +2,454	+56%	+$26.4K	﹤0.01%	3040
2014 Q4	$36K	Buy	+4,391	New	+$37.8K	﹤0.01%	2898

Renaissance Technologies's TBRA Position: Q4 2016 in Review

Renaissance Technologies sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 59,666 shares — an estimated $2.37M sold.

Renaissance Technologies first reported a position in TBRA in Q4 2014 and held it in 8 quarters. The position peaked at $2.37M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Renaissance Technologies reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Renaissance Technologies sold 59,666 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $2.37M.
Renaissance Technologies first reported a position in Tobira Therapeutics, Inc. Common Stock in Q4 2014 and held it in 8 quarters.
Renaissance Technologies's Tobira Therapeutics, Inc. Common Stock position peaked at $2.37M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.